Authors
Munir Escaf, MD
Latest:
Laser therapy may offer fast-acting option for CSR resolutionPatients tolerate therapy well; high safety profile allows re-treatment as necessary
Alex Delaney-Gesing
Latest:
Update on FDA approval of XIPERE for macular edema associated with uveitis from Bausch + LombBausch + Lomb's Yolande Barnard shares an update on the FDA approval of XIPERE for the treatment of macular edema associated with uveitis.
OT Staff Reports
Latest:
Comparing suitable naïve versus pre-treated DME patientsJavier Zarranz-Ventura MD, PhD, FEBO, discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.
Rishi P. Singh, MD
Latest:
ARVO 2025: Rishi Singh, MD, discusses real-world clinical outcomes in patients with DMEIn an analysis of the IRIS database, investigators assessed almost 1,200 eyes that had been treated with faricimab.
Nimesh A. Patel, MD
Latest:
FISH in focus for fast eye infection diagnosisDespite cost, advantages include sensitivity, improved outcomes
Pauline T. Merrill, MD
Latest:
ST laser therapy may reduce DME intravitreal injectionsUsed as an adjunct, ST laser therapy may reduce the treatment burden for patients while maintaining visual acuity.
